Both heparanase-expressing CAR T-cells (130) and hyaluronidase-expressing CAR T-cells (131) have demonstrated increased tumor infiltration and enhanced anti-tumor activity, including when hyaluronidase and IL-7 armoring were combined (132). Here, IL7 is linked to neoplasm.